Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Welcome and opening

Date

02 Dec 2022

Session

Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Topics

Tumour Site

Renal Cell Cancer; Non-Small Cell Lung Cancer; Hepatobiliary Cancers

Presenters

Hwai Loong Kong

Authors

H.L. Kong

Author affiliations

Medical Oncology Department, Icon Cancer Centre - Mount Elizabeth Medical Clinic, 228510 - Singapore/SG

Resources

This content is available to ESMO members and event participants.

Login

Resources from the same session

02 Dec 2022

Current management of NSCLC in Asia Pacific

Presenter: Thanyanan Baisamut (Reungwetwattana)

Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Resources:

Webcast

02 Dec 2022

What’s new in the management of non-mutated NSCLC after progression to immunotherapy treatment

Presenter: Solange Peters

Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Resources:

Webcast

02 Dec 2022

Defining optimal sequencing in HCC with evidence and experience-based discussion

Presenter: Han Chong Toh

Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Resources:

Webcast

02 Dec 2022

How can we further optimize the management of RCC patients

Presenter: Marniza Binti Saad

Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Resources:

Webcast

02 Dec 2022

Panel discussion and closing

Presenter: Solange Peters

Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Resources:

Webcast